Floatz logo

Ticagrelor

Intracranial Arteriosclerosis

University of FloridaSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Intracranial Arteriosclerosis cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Yonsei University
Phase 4BBB
Plavix
Yonsei University
Phase 4BB
Apixaban
Yonsei University
Phase 4BB
Rivaroxaban
University of Florida
Phase 3BB
Tocilizumab
Zhujiang Hospital
Phase 3B

View all 14 →

Same molecule, other indications

Ticagrelor is also rated in:

myocardial infarctionDormant
BBB
Indicative ·
78 / 100
View asset →
ischemic strokeDormant
BBB
Indicative ·
76 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →